Suppression of rhabdomyosarcoma growth by fumagillin analog TNP-470

International Journal of Cancer

Volumn 68, Issue 5, 1996, Pages 596-599

  Kalebic, Thea ^a,b   Tsokos, Maria ^a   Lee Helman, J ^a,b  

^a Pediatric Oncology Branch   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; FUMAGILLIN DERIVATIVE; FUMAGILLOL CHLOROACETYLCARBAMATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL DIVISION; CYCLOHEXANES; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RHABDOMYOSARCOMA; SESQUITERPENES;

EID: 0029829449     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961127)68:5<596::AID-IJC7>3.3.CO;2-X     Document Type: Article

References (19)

1. ABE, J., ZHOU, W., TAKUWA, N., TAGUCHI, J., KUROKAWA, K., KUMADA, M. and TAKUWA, Y., A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelia! cells. Cancer Res.,54,3407-3412 (1994).
2. FOLKMAN, J., Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction. Cancer Metastasis Rev.,9, 171-174 (1990).
3. FOLKMAN, J. and INGBER, D., Inhibition of angiogenesis. Semin. Cancer Biol.,3, 89-96 (1992).
4. GERAN, R.I., GREENBERG, N.H., MACDONALD, MM., SCHUMACHER, A.M. and ABBOTT, B.J., Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother. Rep. Part III, 3,1-103 (1972).
5. HORI, A., IKEYAMA, S. and SUDO, K., Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells. Biochem. biophys. Res. Comm.,204, 1067-1073 (1994).
6. INGBER, D., FUJITA, T., KISHIMOTO, S., SUDO, K., KANAMARU, T., BREM, H. and FOLKMAN, J., Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (Land.), 348, 555-557 (1990).
7. KALEBIC, T., GARBISA, S., GLASER, B. and LIOTTA, L.A., Basement membrane collagen: degradation by migrating endothelial cells. Science, 221, 281-283 (1983).
8. KALEBIC, T., TSOKOS, M. and HELMAN, L.J., In vivo treatment with antibody against 1GF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2. Cancer Res., 54, 5531-5534 (1994).
9. KUSAKA, M., SUDO, K., FUJITA, T., MARUI, S., ITOH, F., INGBER, D. and FOLKMAN, J., Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biocliem. biophys. Res. Comm.,174, 1070-1076 (1991).
10. LIOTTA, L.A., STEEG, P.S. and STETLER-STEVENSON, W.O., Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64,327-336 (1991).
11. MCALLISTER, R.M., MELNYK, J., FINKELSTEIN, J., ADAMS, E.G. and GARDNER, M.B., Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer, 24, 520-526 (1969).
12. MINNITI, C.P., MAGGI, M. and HELMAN, L.J., Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop. Cancer Res.,52, 1830-1835 (1992).
13. NICOLSON, G.L., Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes. Curr. Opin. Oncol.,3, 75-92 (1991).
14. PAPPO, A.S., SHAPIRO, D.N., CRIST, W.M. and MAURER, H.M., Biology and therapy of pédiatrie rhabdomyosarcoma. J. Clin. Oncol.,13, 2123-2139 (1995).
15. 1 cyclins. Cell, 73,1059-1065 (1993).
16. 1 arrest in senescent human fibroblasts. Bioessays, 17, 537-543 (1995).
17. TEICHER, B.A., HOLDEN, S.A., ARA, G., SOTOMAYOR, E.A., HUANG, Z.D., CHEN, Y.N. and BREM, H., Potentiatipn of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int. J. Cancer, 57, 920-925 (1994).
18. YANASE, T., TAMURA, M., FUJITA, K., KODAMA, S. and TANAKA, K., Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res.,53, 2566-2570 (1993).
19. ZETTER, B.R., Migration of capillary endothelial cells is stimulated by tumour-derived factors. Nature (Land.), 285,41-43 (1980).